In recent years, Berlin has developed into one of the startup strongholds in Europe. At the same time, the capital region is a leading location in the life sciences, healthcare industry and healthcare provision. A team led by economist Professor Dr. Hannes Rothe has been commissioned by the Senate Department for Economic Affairs, Energy and Operations to analyze what other reasons there are for the low startup momentum in the biotech sector and how Berlin can catch up with leading regions such as Cambridge/Oxford in the UK.